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 Background: The aim of this study was to assess sleep architecture and respiration during sleep in children with intractable 
epileptic encephalopathies using overnight video-polysomnography (V-PSG).
 Material/Methods: Between 2015 to 2017 overnight V-PSG recordings were made for 31 children (22 boys and 9 girls) with in-
tractable epileptic encephalopathy with a mean age of 6.78±3.61 years and a mean body mass index (BMI) of 
15.83±3.16 kg/m3. Thirty-one healthy children were matched for sex, age, and BMI as the control group. The 
phases of sleep studied included rapid eye movement (REM) sleep, and non-REM (NREM) phases NREM 1, NREM 
2, and NREM 3. Respiratory function during sleep was evaluated.
 Results: Children with epileptic encephalopathies receiving antiepileptic treatment had significantly decreased total 
sleep time (TST) (p=0.038), significantly increased percentage of NREM1 (p=0.033), and a significantly lower 
percentage of total REM (p<0.0001), compared with the control group. All children 31/31 (100%) with epileptic 
encephalopathies had interictal epileptiform discharges, and 4/31 (12.9%) had ictal events. The number of re-
spiratory events did not differ significantly between the two groups (p=0.118), but children in the epileptic en-
cephalopathy group had a significantly shorter average duration (p=0.008) and longest duration (p=0.048) of 
respiratory events. Average (p=0.006) and least (p=0.0004) oxygen saturation (SatO2) were significantly lower 
in children with epileptic encephalopathies compared with the control group.
 Conclusions: Children with epileptic encephalopathies had altered sleep architecture and marked oxygen desaturation, which 
supports the need for referral of children with epileptic encephalopathy for overnight sleep evaluation.
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Background
Epileptic encephalopathies are conditions in which epileptic 
activity directly contributes to cognitive and behavioral impair-
ment that is often greater than that expected from the under-
lying cerebral pathology alone, which implies that suppression 
of epileptiform activity might minimize further functional im-
pairment [1]. Global or selective cognitive and behavioral im-
pairment can become worse over time and can present as a 
spectrum of severity across all forms of epilepsy and at any 
age [1]. Cognitive dysfunction is more severe when seizures oc-
cur in younger age, whereas the later onset of seizures causes 
more selective neuropsychological dysfunction [2,3]. Epileptic 
encephalopathies are rare disorders with an incidence that has 
been reported to range from between 1/10,000 to 1/1,000,000 
live births, representing up to 25% of all forms of pediatric ep-
ilepsy [4,5]. Most patients with epileptic encephalopathy pres-
ent as isolated cases and are presumed to have an underlying 
genetic defect, although in some cases metabolic or structur-
al abnormalities can be identified [6].
Previously published studies have shown that 21% of patients 
with epilepsy have seizures that occur only during sleep, 42% 
occur only when awake, and 37% of patients have seizures in 
when both awake and asleep [7]. Patients with epilepsy can 
experience vicious cycle of seizures in sleep that lead to sleep 
disruption, resulting in a lower seizure threshold that further 
increases the frequency of seizures [8]. Non-rapid eye move-
ment (NREM) sleep synchronizes neuronal networks in the 
reticular activation system of the brainstem, thalamus, and 
cortex. As NREM deepens, the thalamocortical network pro-
gressively hyperpolarizes to facilitate the spread of interictal 
discharges and seizures. Rapid eye movement (REM) sleep in-
hibits the thalamocortical spread of epileptiform discharges 
and promote skeletal muscle paralysis [9].
Up to 20% of children with epilepsy have medically intracta-
ble epilepsy [10], which is defined by at least one seizure per 
month, despite appropriate anti-epileptic therapy with at least 
two antiepileptic drugs, in maximally-tolerated doses for 18 
months, or adequate seizure control but with unacceptable 
drug-related side effects [11].
There have been few previously published studies on the in-
teraction between sleep and epilepsy in the pediatric popu-
lation [12]. Children with partial epilepsy of minor severity 
and treated with up to two antiepileptic drugs have a higher 
prevalence of self-reported sleep disturbances compared with 
healthy children [13]. Children with poorly controlled partial or 
generalized epilepsy have altered sleep architecture and sleep-
disordered breathing [14]. The etiology of sleep disruption in 
children with epilepsy is multifactorial and is due to the ef-
fects of the epileptic seizure and its severity, seizure frequency, 
sleep-disordered breathing, and the effect of antiepileptic med-
ication [12]. There have been even fewer studies using over-
night polysomnography (PSG) to evaluate sleep architecture 
and sleep-disordered breathing in children with epileptic en-
cephalopathies and, so far, results have been inconsistent.
Therefore, the aim of this study was to assess sleep architec-
ture and respiration during sleep in children with intractable 
epileptic encephalopathies using overnight video-polysom-
nography (V-PSG).
Material and Methods
Ethical approval
This study was approved by the Local Ethics Committee. The 
parents of all the children who participated in the study pro-
vided written informed consent for the children to undergo the 
procedures used in the study. The study was undertaken ac-
cording to the principles of the Declaration of Helsinki. All chil-
dren underwent a single night of polysomnographic recording.
Children with epileptic encephalopathies included in the 
study
Between 2015 and 2017, a prospective, controlled, observa-
tional study involved the recording of overnight video-poly-
somnography (V-PSG) for 31 children with epileptic encephalo-
pathies. The children in the study group included two siblings 
with early infantile epileptic encephalopathy-25 (EIEE-25) 
caused by mutation in the SLC13A5 gene; one child with ear-
ly infantile epileptic encephalopathy-13 (EIEE-13) caused by 
mutation in the SCN8A gene; six children with West syndrome; 
four children with Dravet syndrome, previously known as se-
vere myoclonic epilepsy of infancy (SMEI); eight children with 
Lennox-Gastaut syndrome; four children with Landau-Kleffner 
syndrome; and six children with epileptic encephalopathy with 
continuous spikes and waves during sleep (CSWS). Epileptic 
encephalopathy was diagnosed by experienced pediatric neu-
rologists, and the children were being treated with antiepilep-
tic therapy before the study began.
Inclusion and exclusion criteria for the children in the 
study group (n=31) and the control group (n=31)
Prior to V-PSG recording, parents were interviewed for the sleep 
history of the children. All children’s medical records were re-
viewed. Overnight V-PSG was also recorded for 31 children in 
the control group, who were referred to our hospital due to 
the history of past nutritional allergy. The 31 children in the 
control group were matched with the 31 children in the epi-
leptic encephalopathy study group by gender, age, and body 
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mass index (BMI). Children in the control group with the histo-
ry suggestive of sleep-disordered breathing, paroxysmal noc-
turnal events, a previous diagnosis of sleep disorder, or those 
taking any pharmacotherapy were excluded from the study. 
None of the children from both groups had adenotonsillecto-
my before V-PSG. Children from both groups also had a similar 
socio-economic background. Children in both groups were ex-
amined before the overnight V-PSG recording, and only children 
without acute illness underwent the recording. Before over-
night V-PSG, children with epileptic encephalopathy were al-
lowed to take their previously prescribed medication.
Overnight video-polysomnography (V-PSG)
Overnight V-PSG included the use of infrared video camera, 
a microphone to record vocalization during sleep, the use of 
16-channel electroencephalography (EEG) with the placement 
of scalp electrodes performed according to the International 
10-20 system. Left and right electro-oculography (EOG), chin 
electromyography (EMG) using surface electrodes, a nasal pres-
sure transducer and a thermistor for detection of respiratory 
events, thoraco-abdominal plethysmography (strain gauge), 
2nd lead electrocardiography (ECG), sensors for pulse rate, and 
measurement of peripheral blood oxygen saturation (SatO2) 
were performed. The V-PSG recordings were made using the 
Nihon Kohden™ recording system (Nihon Kohden, Shinjuku-
ku, Tokyo, Japan) and stored on a hard disc for further anal-
ysis using Polysmith™ software (Nihon Kohden, Shinjuku-ku, 
Tokyo, Japan). The scoring systems used for the sleep param-
eters were performed according to the criteria of the American 
Academy for Sleep Medicine [15].
Sleep parameters studied
All sleep parameters measured and analyzed by the Polysmith™ 
software (Nihon Kohden, Shinjuku-ku, Tokyo, Japan) used in 
this study were tabulated for statistical analysis. In all subjects, 
sleep was subdivided into 30-second epochs for scoring of sleep 
stages and 2-minute epochs for scoring of respiratory activity. 
As most of the children with epileptic encephalopathy had an 
abnormally slow EEG in awake state and interictal discharg-
es during sleep, standard criteria were slightly modified, and 
sleep stages were scored based on the following [16]. Non-rapid 
eye movement (NREM) sleep stage 1 (NREM 1) was scored af-
ter wakefulness or movement when the EMG tone was dimin-
ished, movement artifacts were absent, and the EEG did not 
show any sleep-specific grapho-elements, for example, sleep 
spindles and K complexes. NREM sleep stage 2 (NREM 2) was 
scored in the presence of sleep spindles or K complexes, even 
between the runs of epileptiform discharges. NREM sleep stage 
3 (NREM 3) was characterized by the presence of nearly contin-
uous high-amplitude slow-wave activity. Rapid eye movement 
(REM) sleep was characterized by decreased EMG tone, rapid 
eye movement on EOG, shorter duration and lower frequency 
of epileptiform discharges when compared with NREM sleep.
Polysomnographic parameters studied
Polysomnographic parameters analyzed included the total re-
cording time (TRT) (time of lights out to time of lights on in 
minutes), the total sleep time (TST) in minutes, the percent-
age of sleep efficiency (SE) (TST/TRT x 100), the sleep latency 
(SL) in minutes (time from lights out to the first of any sleep 
 epochs), stage R latency (RL) in minutes (sleep onset to the first 
epochs of stage R), and the total wake time (TWT) in minutes 
(TRT-TST-SL). Other polysomnographic parameters analyzed 
included the percentage of TST in each sleep stage (time in 
each stage/TST×100), the number of arousals, the total num-
ber of respiratory events, the number and duration of obstruc-
tive and central respiratory events, the apnea-hypopnea index 
(AHI) (the number of apneas + number of hypopneas x 60/TST), 
the average and minimum oxygen saturation (SatO2), and the 
presence of paroxysmal nocturnal events.
Statistical analysis
According to the statistical power analysis performed before 
the study began, the study required the recruitment of at 
least ten children with epileptic encephalopathy and at least 
ten healthy children, and the study included 31 children in the 
study group and 31 children in the control group. Power analy-
sis for the Mann-Whitney U test was performed using G*Power 
for Windows, version 3.1.5, based on the difference in sleep 
parameters between the study group of children with epilep-
tic encephalopathy and the control group of healthy children, 
according to the method of analysis previously reported [17]. 
The following criteria were used, the power of 0.95, the effect 
size of 1.8, and two groups (participants and controls) of simi-
lar size. Statistical analysis of quantitative data was performed 
using the mean ± standard deviation (SD). In the case of non-
parametric distribution, the median and interquartile range (IQR) 
were used. Categorical data were expressed as absolute fre-
quencies and percentages (%). Comparisons between the two 
groups were performed using the Mann-Whitney U test. All p-
values <0.05 were considered statistically significant. Statistical 
analysis was performed using the Statistical Program for Social 
Sciences (SPSS) version 23 (SPSS, Inc., Chicago, IL, USA).
Results
Demographic and clinical characteristics of the children 
with epileptic encephalopathy
The demographic and clinical characteristics of the children 
with epileptic encephalopathy are shown in Table 1.
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Sleep architecture and respiratory sleep parameters
Differences in sleep structure, respiratory parameters, and ox-
ygen saturation (SatO2) between the group of children with 
epileptic encephalopathies and the control group are shown 
in Table 2. The results of this study showed that children with 
epileptic encephalopathy had significantly decreased total sleep 
time (TST) (p=0.038), a significantly lower percentage of rapid 
eye movement (REM) sleep (p<0.0001), and a significantly in-
creased percentage of non-REM (NREM) phase NREM 1 sleep 
stage (p=0.033). The number of respiratory events did not 
differ significantly between the two groups (p=0.118); there 
were 0.00 (IQR 0.00–1.75) respiratory events in the epilep-
tic encephalopathy group vs. 1.00 (IQR 1.00–1.75) in the con-
trol group, but children in the epileptic encephalopathy group 
had significantly shorter mean duration (p=0.008) and longest 
duration (p=0.048) of respiratory events. The mean SatO2 in 
children with epileptic encephalopathy was significantly low-
er with a median of 98.00% (IQR, 97.00–98.00; average rank, 
25.55) versus a median of 98.00% (IQR, 98.00–99.00; average 
rank, 37.45) in the control group (p=0.006). The lowest levels 
of SatO2 were also significantly lower in children with epileptic 
encephalopathy, with a median of 91.00% (IQR, 90.00–94.00; 
average rank 23.40) versus a median of 93% (IQR, 93.00–94.00; 
average rank, 39.59) in the control group (p=0.0004). The ap-
nea-hypopnea index (AHI) did not differ significantly between 
the two study groups (p=0.27).
Discussion
The aim of our study was to evaluate sleep architecture and 
respiration in children with intractable epileptic encephalop-
athies, using overnight video-polysomnography (V-PSG). The 
main findings of this study showed that, compared with a 
normal population of children matched for age, sex, and body 
mass index (BMI), children with epileptic encephalopathies had 
a significantly decreased total sleep time (TST) (p=0.038), a 
significantly lower percentage of time in the rapid eye move-
ment (REM) sleep (p<0.0001), and a significantly increased per-
centage of time in non-REM stage 1 (NREM 1) sleep (p=0.033).
Nunes et al. [18] have also reported reduced total sleep time 
in 17 children with refractory focal epilepsy, which these au-
thors explained as being due either to the epileptic syndrome 
or to the chronic use of antiepileptic drugs. Data from previ-
ously published studies using polysomnography in children 
with epilepsy are highly variable in terms of methodology, de-
mographic, and clinical features of the children studied, which 
could be the reason for conflicting results of the duration of 
sleep phases. However, the findings of the present study are 
supported by those of Maganti et al. Who showed an increase 
in NREM 1 sleep stage in 11 school-aged children with primary 
generalized epilepsy [19]. Other polysomnographic studies have 
reported reduced REM sleep [18,20] and delayed REM latency 
in children with epilepsy [19,20]. However, Kaleyias et al. [14] 
showed a higher percentage of REM sleep in children with 
poorly controlled partial and generalized epilepsy.
An Italian study of 23 children with epileptic encephalopathy, 
which included 14 children with Lennox-Gastaut syndrome, 
five children with Dravet syndrome and four children with ep-
ilepsy with myoclonic-atonic seizures, reported reduced total 
Age (years) (c
_
±SD) 6.78±3.61
Male/Female 22/9
Body Mass Index (kg/m2) (c
_
± SD) 15.83±3.16
Cause of epileptic encephalopathies
 Structural
 Genetic
 Unknown
 13/31 (41.93%)
 9/31 (29.03%)
 9/31 (29.03%)
Antiepileptic therapy
 Monotherapy
 Polytherapy
  2 antiepileptic drugs
  3 antiepileptic drugs
  4 antiepileptic drugs
 Ketogenic diet
 7/31 (22.58%)
 10/31 (32.25%)
 8/31 (25.80%)
 5/31 (16.13%)
 1/31 (3.22%)
Antiepileptic drugs
 Valproates
 Clobazam
 Levetiracetam
 Oxcarbazepin
 Topiramat
 Ethosuximide
 Vigabatrin
 Lamotrigin
 Rufinamide
 Zonisamide
 17/30 (56.66%)
 14/30 (46.67%)
 7/30 (23.33%)
 6/30 (20.00%)
 5/30 (16.67%)
 5/30 (16.67%)
 4/30 (13.33%)
 3/30 (10.00%)
 1/30 (3.33%)
 1/30 (3.33%)
Sleep history (parent report)
 Never/seldom sleeps restlessly
  Never/seldom stops breathing in 
sleep
 Daily drowsiness
 23/31 (74.1%)
 23/31 (74.1%)
 25/31 (80.64%)
Encephalographic epileptiform 
activity
 Interictal
 Ictal events 
 31/31 (100%)
 4/31 (12.9%)
Table 1.  Demographic and clinical characteristics of children with 
epileptic encephalopathies.
Values are expressed as absolute numbers and percentage, 
unless otherwise specified. Children in the epileptic 
encephalopathy and control group were matched for sex, age 
(p=0.98) and BMI (p=0.26).
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sleep time (TST), longer REM latency, and increased NREM 3, 
compared with a group of healthy children [17]. However, a 
contradictory finding was shown in polysomnographic studies 
on five children with Dravet syndrome, which did not demon-
strate disturbance in sleep architecture [21].
Hrackovy et al. found reduced total sleep time (TST) and a sig-
nificantly reduced percentage of REM sleep in 32 patients with 
infantile spasms, compared with normal values for the age of 
the study population [22]. Subgroup analysis of patients with 
a higher percentage of REM sleep in the same study showed 
that this was associated with clinical and encephalographic 
V-PSG parameter
Children with EE (N=31)
Median (IQR)
Control group (N=31)
Median (IQR)
Mann Whitney U test
U p-Value
TRT (min)
462.00
(432.50–499.25)
486.00
(460.25–506.25)
364.00 0.101
TST (min)
395.00
(326.25–429.25)
414.00
(395.25–432.75)
333.50 0.038
SE (%)
82.99
(70.81–88.90)
87.30
(81.70–90.74)
369.00 0.116
SL (min)
27.00
(11.25–45.12)
23.00
(11.25–43.00)
459.00 0.761
RL (min)
124.00
(69.00–177.00)
109.50
(74.00–147.00)
392.00 0.391
TWT (min)
45.00
(17.25–74.50)
24.00
(18.00–48.00)
407.50 0.304
Sleep efficiency (%)
88.16
(77.65–96.46)
93.08
(87.57–96.40)
368.00 0.113
N1%
2.10
(1.10–3.08)
1.40
(1.03–1.88)
329.00 0.033
N2%
46.60
(31.53–53.98)
43.10
(37.10–48.43)
448.00 0.647
N3%
27.90
(17.55–44.70)
31.60
(26.17–33.85)
408.00 0.307
REM%
13.80
(8.40–16.78)
19.80
(17.60–22.20)
146.50 P<0.0001
Number of arousals (N)
7.5
(3.00–10.00)
8.00
(6.00–10.00)
286.00 0.340
Number of respiratory events (N)
0.00
(0.00–1.75)
1.00
(1.00–1.75)
374.50 0.118
Average duration of respiratory 
events (s)
0.00
(0.00–10.00)
10.00
(8.25–12.00)
297.00 0.008
Longest duration of respiratory 
events (s)
0.00
(0.00–11.75)
10.00
(8.25–12.00)
343.50 0.048
Apnea-Hypopnea Index (AHI)
0.00
(0.00–0.26)
0.15
(0.12–0.24)
404.50 0.27
Average sat02 (%)
98.00
(97.00–98.00)
25.55*
98.00
(98.00–99.00)
37.45*
296.00 0.0061
Miminum sat02 (%)
91.00
(90.00–94.00)
23.40*
93.00
(93.00–94.00)
39.59*
229.50 0.0004
Table 2.  Differences in sleep structure, respiratory parameters and sat02 between the group of children with epileptic 
encephalopathies and the control group.
* Average rank.
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improvement [22]. Therefore, it might be possible that the pro-
portion of REM sleep could serve as a marker of intractable 
epileptic encephalopathy [23]. Beside the dysfunction of ace-
tylcholine neurons in the pedunculopontine nucleus, which is 
the origin of REM sleep, REM duration could also be affected 
by sleep fragmentation due to interictal discharges and antiep-
ileptic drug treatment [24]. The findings of the present study, 
showing disturbed sleep architecture in children with epilep-
tic encephalopathy, are in some agreement with the findings 
of previously published studies. However, the variable results 
among the studies could be due to different types of epilepsy 
studied, the different clinical stages of epilepsy involved, the 
extent of interictal discharges, and the effects of different an-
ticonvulsant treatment [25,26].
Antiepileptic drugs can alter sleep in both positive and neg-
ative ways, independent of their anticonvulsive actions [27]. 
Antiepileptic drugs inhibit neuronal excitability but also stabilize 
sleep, reduce sleep transitions, and reduce seizure rates [12]. 
The number of antiepileptic drugs used for each child is also 
an important factor in the analysis of their effects on sleep, 
as it has been previously shown the more antiepileptic drugs 
that are used, the more sleep efficiency and REM sleep is 
likely to be reduced [28]. Most of the children in the present 
study were treated with valproates 17/31 (56.6%), and data 
on the effect of valproates on sleep are variable; some stud-
ies have shown no alteration in sleep architecture [29], other 
studies have shown that valproates reduce REM sleep and in-
crease NREM1 sleep [30]. In the present study, 14/31 children 
(46.6%) were treated with clobazam, which has been shown 
by a previously published randomized, double-blind, placebo-
controlled study to reduce sleep latency, NREM 1, and NREM 
3, and to increase NREM 2 [31]. Data from previously pub-
lished studies on the effects of carbamazepine are more vari-
able, but it seems that it reduces sleep latency and arousal, 
and increases sleep efficiency and NREM 3 [32]. A placebo-
controlled study on healthy volunteers found no effect of le-
vetiracetam on sleep structure [33], while another randomized 
placebo-controlled double-blind study reported an increase in 
total sleep time (TST), sleep efficiency, NREM 2, and a reduc-
tion in REM sleep [34]. Also, the impact of antiepileptic drugs 
on sleep is dose-dependant and could be modulated by co-
administration of other antiepileptic drugs [35].
In terms of sleep disturbance, in the present study, the par-
ents of the children with epileptic encephalopathy reported 
that 23/31 (74.1%) usually slept calmly, and 25/31 (80.64%) 
of children with epileptic encephalopathy were drowsy during 
the day, which could be explained by the effects of the anti-
epileptic drugs. Due to the small sample and cohort hetero-
geneity, it was not possible to evaluate the impact of individ-
ual and combined antiepileptic therapy on sleep parameters 
in this study. Furthermore, sleep architecture can be abnormal 
due to the epileptic syndrome itself, independent of antiepi-
leptic drug effects, which is in keeping with the finding in this 
study of ictal events and interictal epileptiform discharges 
(less pronounced in REM phase) contributing to sleep disrup-
tion. This finding is supported by the findings of a study pub-
lished by Becker et al., who reported that children with epi-
lepsy had disrupted sleep even during the seizure-free nights 
when compared with healthy controls, due to interictal dis-
charges that prevent normal progression through the stages of 
sleep [36]. Interictal discharges can alter normal sleep grapho-
elements, for example, lower amplitude of sleep spindles and 
intrude into NREM and REM sleep [37], and sleep can also ac-
tivate and change the morphology of interictal discharges [26].
In the present study, the number of respiratory events did not dif-
fer significantly between the study group and the control group 
(p=0.118), but in the epileptic encephalopathy group, duration 
of respiratory events was significantly shorter for both average 
duration (p=0.008) and longest duration (p=0.048). The aver-
age and lowest oxygen saturation (SatO2) was also significantly 
lower in children with epileptic encephalopathy (p=0.006) and 
(p=0.0004), respectively. The apnea-hypopnea index (AHI) did 
not differ significantly between the two study groups (p=0.27).
In this study, the body mass index (BMI) of all the children in 
both groups were in the normal range, according to the WHO 
Child Growth Standards [38]. In a study by Kaleyias et. al. [14], 
which reported that 42% of children with epilepsy had sleep-dis-
ordered breathing, one of the reasons for this opposing results 
could be the high BMI of children in their study, with a median 
BMI of 29 kg/m2 (IQR, 27–37) compared with the normal BMI of 
children in the present study of 16.98 kg/m2 (IQR, 14–18). Also, it 
is important to highlight that the present study showed a signifi-
cant sleep-associated oxygen desaturation in children with epilep-
tic encephalopathy, which could have been due to several factors 
including, differences in autonomic control of ventilation [39], the 
nature of the epileptic syndrome, the type and number of antiep-
ileptic drugs, and the anatomy of the upper respiratory tract [14].
This study had several limitations. Children were recruited to 
the study who had different types of epileptic encephalopa-
thy in different clinical stages, and who were already receiv-
ing anticonvulsant treatment. Only one night of polysomnog-
raphy recording was performed per child. However, a previous 
study has reported that there is little variability between the 
first and second night of polysomnography recording in the 
data on sleep structure and respiratory parameters and there-
fore two consecutive polysomnographic recordings may not 
be necessary [40]. To the best of our knowledge, this is the 
largest cohort overnight V-PSG study in children with intrac-
table epileptic encephalopathies, and the findings might pro-
vide further insight into sleep disorders in this group of chil-
dren and form the basis for further research.
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Conclusions
The findings of a video-polysomnographic (V-PSG) study in 31 
children with epileptic encephalopathy receiving antiepilep-
tic treatment, showed altered sleep architecture, and although 
the number of respiratory events was not significantly differ-
ent from a normal controlled population of children, there was 
a significant reduction in oxygen saturation (SatO2). All children 
in the study group had interictal epileptiform discharges, and 
four of them had ictal events. The findings of this study support 
referral of children with epileptic encephalopathy for the eval-
uation of sleep architecture and respiratory patterns. Further 
multicenter investigations are needed to determine sleep phe-
notypes in children with specific forms of epileptic encephalop-
athies that could lead to prescription of adequate antiepilep-
tic drug combinations.
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